Decreased clinical performance in TGA-ASO patients after RVOT interventions; a multicenter European collaboration.

Arterial switch operation Peak-VO2 Re-intervention Right ventricular outflow tract obstruction Transposition of the great arteries

Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
05 Apr 2024
Historique:
received: 23 07 2023
revised: 13 03 2024
accepted: 04 04 2024
pubmed: 8 4 2024
medline: 8 4 2024
entrez: 7 4 2024
Statut: aheadofprint

Résumé

In patients with transposition of the great arteries and an arterial switch operation (TGA-ASO) right ventricular outflow tract (RVOT) obstruction is a common complication requiring one or more RVOT interventions. We aimed to assess cardiopulmonary exercise capacity and right ventricular function in patients stratified for type of RVOT intervention. TGA-ASO patients (≥16 years) were stratified by type of RVOT intervention. The following outcome parameters were included: predicted (%) peak oxygen uptake (peak VO2), tricuspid annular plane systolic excursion (TAPSE), tricuspid Lateral Annular Systolic Velocity (TV S'), right ventricle (RV)-arterial coupling (defined as TAPSE/RV systolic pressure ratio), and N-terminal proBNP (NT-proBNP). 447 TGA patients with a mean age of 25.0 (interquartile range (IQR) 21-29) years were included. Patients without previous RVOT intervention (n = 338, 76%) had a significantly higher predicted peak VO2 (78.0 ± 17.4%) compared to patients with single approach catheter-based RVOT intervention (73.7 ± 12.7%), single approach surgical RVOT intervention (73.8 ± 28.1%), and patients with multiple approach RVOT intervention (66.2 ± 14.0%, p = 0.021). RV-arterial coupling was found to be significantly lower in patients with prior catheter-based and/or surgical RVOT intervention compared to patients without any RVOT intervention (p = 0.029). TGA patients after a successful arterial switch repair have a decreased exercise capacity. A considerable amount of TGA patients with either catheter or surgical RVOT intervention perform significantly worse compared to patients without RVOT interventions.

Sections du résumé

BACKGROUND BACKGROUND
In patients with transposition of the great arteries and an arterial switch operation (TGA-ASO) right ventricular outflow tract (RVOT) obstruction is a common complication requiring one or more RVOT interventions.
OBJECTIVES OBJECTIVE
We aimed to assess cardiopulmonary exercise capacity and right ventricular function in patients stratified for type of RVOT intervention.
METHODS METHODS
TGA-ASO patients (≥16 years) were stratified by type of RVOT intervention. The following outcome parameters were included: predicted (%) peak oxygen uptake (peak VO2), tricuspid annular plane systolic excursion (TAPSE), tricuspid Lateral Annular Systolic Velocity (TV S'), right ventricle (RV)-arterial coupling (defined as TAPSE/RV systolic pressure ratio), and N-terminal proBNP (NT-proBNP).
RESULTS RESULTS
447 TGA patients with a mean age of 25.0 (interquartile range (IQR) 21-29) years were included. Patients without previous RVOT intervention (n = 338, 76%) had a significantly higher predicted peak VO2 (78.0 ± 17.4%) compared to patients with single approach catheter-based RVOT intervention (73.7 ± 12.7%), single approach surgical RVOT intervention (73.8 ± 28.1%), and patients with multiple approach RVOT intervention (66.2 ± 14.0%, p = 0.021). RV-arterial coupling was found to be significantly lower in patients with prior catheter-based and/or surgical RVOT intervention compared to patients without any RVOT intervention (p = 0.029).
CONCLUSIONS CONCLUSIONS
TGA patients after a successful arterial switch repair have a decreased exercise capacity. A considerable amount of TGA patients with either catheter or surgical RVOT intervention perform significantly worse compared to patients without RVOT interventions.

Identifiants

pubmed: 38583591
pii: S0167-5273(24)00621-1
doi: 10.1016/j.ijcard.2024.132027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132027

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Leo J Engele (LJ)

CAHAL, Center for Congenital Heart Disease Amsterdam-Leiden, location Amsterdam University Medical Center, Amsterdam, the Netherlands.

Víctor González-Fernández (V)

Hospital Universitari Vall d'Hebron, CIBERCV and European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD Heart), Barcelona, Spain.

Barbara J M Mulder (BJM)

CAHAL, Center for Congenital Heart Disease Amsterdam-Leiden, location Amsterdam University Medical Center, Amsterdam, the Netherlands.

Francisco Javier Ruperti-Repilado (FJ)

University Hospital, University of Basel, Switzerland.

Raquel Ladrón Abia (RL)

Hospital Universitario Virgen del Rocio and European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD Heart), Seville, Spain.

Kim van der Vlist (K)

CAHAL, Center for Congenital Heart Disease Amsterdam-Leiden, location Amsterdam University Medical Center, Amsterdam, the Netherlands.

Francisco Buendía (F)

Hospital Universitari i Politècnic La Fe and CIBERCV, València, Spain.

Joaquin Rueda (J)

Hospital Universitari i Politècnic La Fe and CIBERCV, València, Spain.

Harald Gabriel (H)

Medical University of Vienna, Austria.

Lore Schrutka (L)

Medical University of Vienna, Austria.

Judith Bouchardy (J)

University Hospital Lausanne, Switzerland; University Hospital of Geneva, Switzerland.

Markus Schwerzmann (M)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Mathias Possner (M)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Matthias Greutmann (M)

University Heart Center Zurich, Switzerland.

Pastora Gallego (P)

Hospital Universitario Virgen del Rocio and European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD Heart), Seville, Spain.

Magalie Ladouceur (M)

Hôpital Européen Georges Pompidou, AP-HP, Paris Cité University, Centre de Recherche Cardiovasculaire de Paris, INSERM U970, Paris, France.

Monique R M Jongbloed (MRM)

CAHAL, Center for Congenital Heart Disease Amsterdam-Leiden, location Leiden University Medical Center, Department of Cardiology and Anatomy & Embryology, Leiden, the Netherlands.

Daniel Tobler (D)

University Hospital, University of Basel, Switzerland.

Laura Dos (L)

Hospital Universitari Vall d'Hebron, CIBERCV and European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD Heart), Barcelona, Spain.

Berto J Bouma (BJ)

CAHAL, Center for Congenital Heart Disease Amsterdam-Leiden, location Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: b.j.bouma@amsterdamumc.nl.

Classifications MeSH